Acuta Capital Partners’s Surrozen SRZN Stock Holding History
Bought
Maintained
Sold
Other funds holding SRZN
CG
TCM
BCM
VA
SC
PA
SSC
Acuta Capital Partners's SRZN Position: Q2 2026 in Review
Acuta Capital Partners increased its Surrozen (SRZN) stake by 0.32% in Q2 2026, buying an estimated $15.1K and bringing the position to 173,395 shares worth $4.5M. The position accounts for 3.14% of the portfolio, ranked #10.
Acuta Capital Partners first reported a position in SRZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.04M in Q1 2026. 70 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.
- Acuta Capital Partners held 173,395 shares of Surrozen worth $4.5M as of Q2 2026.
- Acuta Capital Partners bought 548 Surrozen shares in Q2 2026, an estimated $15.1K.
- Surrozen made up 3.14% of Acuta Capital Partners's portfolio in Q2 2026, its #10 holding.
- Acuta Capital Partners first reported a position in Surrozen in Q1 2025 and has held it in 6 quarters since.
- Acuta Capital Partners's Surrozen position peaked at $5.04M in Q1 2026.
- 70 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.
Based on Acuta Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.